Paul Tudor Jones’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Paul Tudor Jones’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,000	Closed	-$3.17M	–	2904
2023 Q4	$3.17M	Buy	+10,000	New	+$1.94M	0.03%	871

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Paul Tudor Jones's KRTX Position: Q4 2022 in Review

Paul Tudor Jones sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2022, closing a stake of 16,965 shares — an estimated $3.82M sold.

Paul Tudor Jones first reported a position in KRTX in Q1 2021 and held it in 4 quarters. The position peaked at $3.82M in Q3 2022. 248 funds tracked by Wall St. Rank hold KRTX as of Q4 2022.

Paul Tudor Jones reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Paul Tudor Jones sold 16,965 Karuna Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $3.82M.
Paul Tudor Jones first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
Paul Tudor Jones's Karuna Therapeutics, Inc. Common Stock position peaked at $3.82M in Q3 2022.
248 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.